• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
NUVA

NUVA

NuVasive, Inc.

NASDAQHealthcareMedical - DevicesUS

USD39.75

-0.91 (-2.24%)

Company Profile

CEO

J. Christopher Barry

IPO Date

2004-05-13

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$40.62

Prev. Close

$40.66

Day Low

$39.51

Day High

$40.96

52W Low

$35.17

52W High

$49.53

Market Cap

$2.08B

Volume

30.59M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

49.5%

Avg Negative

5.5%

Avg Neutral

44.9%

News Feed

NuVasive Receives Latest FDA 510(k) Clearance for Pulse Platform and Announces Commercial Launch

PRNewsWire·7/30/2021·↑ positive

NuVasive (NUVA) Q2 Earnings Beat Estimates, Gross Margin Up

Zacks Investment Research·7/29/2021·↑ positive

NuVasive, Inc. (NUVA) CEO Chris Barry on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/28/2021·↓ negative

NuVasive (NUVA) Beats Q2 Earnings and Revenue Estimates

Zacks Investment Research·7/28/2021·↑ positive

NuVasive Announces Second Quarter 2021 Financial Results

PRNewsWire·7/28/2021·↑ positive

NuVasive (NUVA) Launches Modulus ALIF for Anterior Spine Surgery

Zacks Investment Research·7/23/2021·↑ positive

NuVasive Launches Modulus ALIF 3D-Printed Porous Titanium Implant for Anterior Spine Surgery

PRNewsWire·7/22/2021·↑ positive

NuVasive Announces Conference Call and Webcast of Second Quarter 2021 Results

PRNewsWire·7/14/2021·↑ positive

FDA Flags Certain Biocompatibility Concerns For NuVasive's Orthopedics' Precice Devices

Benzinga·7/9/2021·↓ negative

NuVasive Receives Latest CE Mark Approval for Pulse Platform and Starts Global Clinical Evaluations

PRNewsWire·6/30/2021·↑ positive